Overview

Safety and Effectiveness of TRIZIVIR (Abacavir/Lamivudine/Zidovudine) With Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Status:
Unknown status

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine the effect of treatment with Trizivir (TZV) plus efavirenz (EFV) or TZV alone on viral load (level of HIV in the blood).

Phase:

Phase 4

Details

Lead Sponsor:

GlaxoSmithKline

Treatments:

Abacavir
Dideoxynucleosides
Efavirenz
Lamivudine
Lamivudine, zidovudine drug combination
Zidovudine